✦ LIBER ✦

Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancer

✍ Scribed by Ryotaro Morinaga; Isamu Okamoto; Yoshihiko Fujita; Tokuzo Arao; Masaru Sekijima; Kazuto Nishio; Hiroyuki Ito; Masahiro Fukuoka; Jun-ichi Kadota; Kazuhiko Nakagawa

Book ID: 108584340
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 195 KB
Volume: 99
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2008.00962.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs)

✍ Elena María Martínez-Navarro; Joseba Rebollo; Ramón González-Manzano; Manuel Sur 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 230 KB

Clinical outcomes of advanced non-small

Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations

✍ Kimihide Yoshida; Yasushi Yatabe; Jangchul Park; Shizu Ogawa; Ji Young Park; Jun 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 484 KB

Influence of epidermal growth factor rec

Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer

✍ Makoto Sonobe; Masatsugu Nakagawa; Kazumasa Takenaka; Hiromichi Katakura; Masash 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract ## Background and Objectives In this paper we examined the influence of epidermal growth factor receptor (EGFR) gene mutations on EGFR expression, downstream mediators, and survival in patients with non‐small cell lung cancer (NSCLC). ## Methods We retrospectively analyzed the tumors

Mutations in the epidermal growth factor

Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers

✍ Takayuki Fukui; Tetsuya Mitsudomi 📂 Article 📅 2008 🏛 Springer Japan 🌐 Japanese ⚖ 265 KB

Clinical impact of amphiregulin expressi

Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors

✍ Myung Hee Chang; Hee Kyung Ahn; Jeeyun Lee; Chan-Kwon Jung; Yoon-La Choi; Yeon H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 2 views

Novel monoclonal antibody specific for t

Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene

✍ Terrance G. Johns; Elisabeth Stockert; Gerd Ritter; Achim A. Jungbluth; H-J. Su 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 592 KB

## Abstract In some respects, the EGFR appears to be an attractive target for tumor‐targeted antibody therapy: it is overexpressed in many types of epithelial tumor and inhibition of signaling often induces an anti‐tumor effect. The use of EGFR specific antibodies, however, may be limited by uptake